2700896-73-5

2700896-73-5 structure

Name: BChE-IN-13
Chemical Name: BChE-IN-13
CAS Number: 2700896-73-5
Molecular Formula: C₂₄H₂₈N₂O
Molecular Weight: 360.49
Catalog: Signaling Pathways Neuronal Signaling AChE
Create Date: 2022-10-12 10:26:24
Modify Date: 2024-01-03 20:23:24
BChE-IN-13 (Compound 17c) is an orally active, potent and selective Butyrylcholinesterase (BChE) inhibitor with IC50s of 0.22 and 0.016 μM for eqBChE and hBChE, respectively. BChE-IN-13 can improve memory and cognitive impairments, and be used in Alzheimer’s disease (AD) research[1].

Name	BChE-IN-13

Description	BChE-IN-13 (Compound 17c) is an orally active, potent and selective Butyrylcholinesterase (BChE) inhibitor with IC50s of 0.22 and 0.016 μM for eqBChE and hBChE, respectively. BChE-IN-13 can improve memory and cognitive impairments, and be used in Alzheimer’s disease (AD) research[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> Neuronal Signaling >> AChE
Target	IC50: 0.22 μM (eqBChE) 0.016 μM (hBChE)[1]
In Vitro	BChE-IN-13 (5-100 μM; 24 h) shows weak toxicity to SH-SY5Y, PC-12 and HT-22, and shows high mortality to BV2 cells[1]. BChE-IN-13 shows excellent blood brain barrier permeation using a parallel artificial membrane permeability assay experiment (PAMPA)[1]. Cell Cytotoxicity Assay[1] Cell Line: SH-SY5Y, PC12, BV2 and HT-22 cells Concentration: 5-100 μM Incubation Time: 24 hours Result: Showed cells viability more than 60% of SH-SY5Y, PC-12 and HT-22 even at 100 μM. Showed high mortality in BV2 cells, and reached half the mortality at 20 μM.
In Vivo	BChE-IN-13 (oral gavage; 15 mg/kg; once daily; 6 d) shows the improvement in memory and cognitive function in Aβ1-42 induced AD-like disorder mice[1]. Animal Model: ICR mice intracerebroventricularly (icv) injected with oligomerized Aβ1-42 Dosage: 15 mg/kg Administration: Oral gavage; 15 mg/kg; once daily; 6 days Result: Improved the memory and cognitive function, and showed a shorter latency compared with Donepezil.
References	[1]. Xin Lu, et al. Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease.

Molecular Formula	C₂₄H₂₈N₂O
Molecular Weight	360.49

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2700896-73-5	136966-86-4
2185837-61-8	2421121-10-8
2416910-85-3	2304818-41-3
2700896-78-0	2653349-78-9
2468035-31-4	1403255-41-3
13675-35-9	1036396-79-8
1253415-36-9	1036395-35-3
2229526-99-0	926279-70-1
926279-69-8	1036400-61-9
1036396-72-1	1186544-42-2